Capital Advisory Group Advisory Services’s iBio IBIO Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20	Closed	-$2K	–	136
2022 Q3	$2K	Hold	20	–	–	﹤0.01%	141
2022 Q2	$3K	Hold	20	–	–	﹤0.01%	197
2022 Q1	$4K	Buy	+20	New	+$4.18K	﹤0.01%	450
2021 Q4	–	Sell	-20	Closed	-$11K	–	309
2021 Q3	$11K	Hold	20	–	–	﹤0.01%	383
2021 Q2	$15K	Hold	20	–	–	0.01%	361
2021 Q1	$15K	Hold	20	–	–	0.01%	343
2020 Q4	$11K	Hold	20	–	–	﹤0.01%	357
2020 Q3	$20K	Hold	20	–	–	0.01%	267
2020 Q2	$22K	Hold	20	–	–	0.01%	250
2020 Q1	$11K	Buy	+20	New	+$7.7K	0.01%	225

Other funds holding IBIO

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Capital Advisory Group Advisory Services's IBIO Position: Q4 2022 in Review

Capital Advisory Group Advisory Services sold out of iBio (IBIO) in Q4 2022, closing a stake of 20 shares — an estimated $2K sold.

Capital Advisory Group Advisory Services first reported a position in IBIO in Q1 2020 and held it in 10 quarters. The position peaked at $22K in Q2 2020. 36 funds tracked by Wall St. Rank hold IBIO as of Q4 2022.

Capital Advisory Group Advisory Services reported no remaining iBio position as of Q4 2022 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 20 iBio shares in Q4 2022, an estimated $2K.
Capital Advisory Group Advisory Services first reported a position in iBio in Q1 2020 and held it in 10 quarters.
Capital Advisory Group Advisory Services's iBio position peaked at $22K in Q2 2020.
36 funds tracked by Wall St. Rank held iBio as of Q4 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q4 2022, filed 14 Feb 2023.